We’ve put some small files called cookies on your device to make our site work.
We’d also like to use analytics cookies. These send information about how our site is used to a service called Google Analytics. We use this information to improve our site.
Let us know if this is OK. We’ll use a cookie to save your choice. You can read more about our cookies before you choose.
Your feedback matters and will make a difference.
Help us understand your digital experience by taking our 10 minute survey. Your responses are completely anonymous.
Start the survey.
Clinical commissioning statement: parenteral nutrition for the treatment of adults and children with type 2 and type 3 intestinal failure requiring home parenteral nutrition
This commissioning statement sets out the treatment pathway for patients of all ages with type 2 and type 3 intestinal failure (IF) who require home parenteral support (HPS), including home parenteral nutrition (HPN), and provides a treatment algorithm of current commissioned treatments.